ReviewJournal of hematology & oncology2018

Novel agents for pancreatic ductal adenocarcinoma: emerging therapeutics and future directions.

Yiyin Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.